Literature DB >> 22766747

Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Cristina Stasi1, Massimo Rosselli, Massimo Bellini, Giacomo Laffi, Stefano Milani.   

Abstract

The interaction between the brain and the gut as a pathological mechanism of functional gastrointestinal disorders has been recently recognized in the pathophysiology of the irritable bowel syndrome. Communication between central nervous system and enteric nervous system is two-directional: the brain can influence the function of the enteric nervous system and the gut can influence the brain via vagal and sympathetic afferents. In patients with irritable bowel syndrome, symptoms may be caused by alterations either primarily in the central nervous system (top-down model), or in the gut (bottom-up model), or in a combination of both. The brain-gut axis may be stimulated by various stressors either directed to the central nervous system (exteroreceptive stress) or to the gut (interoceptive stress). Particularly, clinical evidence suggest that in complex and multifactorial diseases such as irritable bowel syndrome, psychological disorders represent significant factors in the pathogenesis and course of the syndrome. Neuroimaging techniques have shown functional differences between central process in healthy subjects and patients with irritable bowel syndrome. Moreover, a high prevalence of psychological/psychiatric disorders have been reported in IBS patients compared to controls. Several data also suggest an alteration of neuro-endocrine and autonomic output to the periphery in these patients. This review will examine and discuss the complex interplay of neuro-endocrine-immune pathways, closely associated with neuropsychiatric disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22766747     DOI: 10.1007/s00535-012-0627-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  75 in total

1.  Central processing of rectal pain: a functional MR imaging study.

Authors:  M V Baciu; B L Bonaz; E Papillon; R A Bost; J F Le Bas; J Fournet; C M Segebarth
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

Review 2.  The neurobiology of stress and gastrointestinal disease.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

3.  Comorbidity of posttraumatic stress disorder and irritable bowel syndrome.

Authors:  C Irwin; S A Falsetti; R B Lydiard; J C Ballenger; C D Brock; W Brener
Journal:  J Clin Psychiatry       Date:  1996-12       Impact factor: 4.384

Review 4.  Tachykinins in the gut. Part I. Expression, release and motor function.

Authors:  P Holzer; U Holzer-Petsche
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

5.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

6.  Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation.

Authors:  M A Cole; B A Kalman; T W Pace; F Topczewski; M J Lowrey; R L Spencer
Journal:  J Neuroendocrinol       Date:  2000-10       Impact factor: 3.627

Review 7.  Interactions between NPY and CRF in the amygdala to regulate emotionality.

Authors:  Tammy J Sajdyk; Anantha Shekhar; Donald R Gehlert
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

8.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

Review 9.  Neuropathophysiology of irritable bowel syndrome.

Authors:  Jackie D Wood
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

10.  Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.

Authors:  J Steens; P J Van Der Schaar; C Penning; J Brussee; A A M Masclee
Journal:  Neurogastroenterol Motil       Date:  2002-06       Impact factor: 3.598

View more
  46 in total

Review 1.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Gastric sensitivity and reflexes: basic mechanisms underlying clinical problems.

Authors:  Fernando Azpiroz; Christine Feinle-Bisset; David Grundy; Jan Tack
Journal:  J Gastroenterol       Date:  2013-12-04       Impact factor: 7.527

3.  The PNEI holistic approach in coloproctology.

Authors:  M Pescatori; V Podzemny; L C Pescatori; M P Dore; G Bassotti
Journal:  Tech Coloproctol       Date:  2015-03-29       Impact factor: 3.781

4.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

5.  Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Sai-Yue Liu; Qin-Qin Yang; Tang-Biao Shen
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 6.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

Review 7.  What goes around comes around: novel pharmacological targets in the gut-brain axis.

Authors:  Camila González-Arancibia; Jorge Escobar-Luna; Camila Barrera-Bugueño; Camilo Díaz-Zepeda; María P González-Toro; Loreto Olavarría-Ramírez; Francesca Zanelli-Massai; Martin Gotteland; Javier A Bravo; Marcela Julio-Pieper
Journal:  Therap Adv Gastroenterol       Date:  2016-02-17       Impact factor: 4.409

8.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

9.  Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.

Authors:  Cristina Stasi; Massimo Bellini; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Mariano Grosso; Emiliano Duranti; Maria Rosaria Metelli; Dario Gambaccini; Lea Bianchi; Gian Luca Di Tanna; Giacomo Laffi; Stefano Taddei; Santino Marchi
Journal:  Int J Colorectal Dis       Date:  2013-02-02       Impact factor: 2.571

Review 10.  Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.

Authors:  C Stasi; M Bellini; G Bassotti; C Blandizzi; S Milani
Journal:  Tech Coloproctol       Date:  2014-01-15       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.